CNSP
NASDAQ
US
CNS Pharmaceuticals, Inc. - Common Stock
$2.26
▼ $-0.02
(-0.66%)
Vol 12K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$3.3M
ROE
-130.1%
D/E
0.31
Beta
0.51
52W
$5–$114
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Earnings
Beat rate: 60.0%
Next Report
May 13, 2026
EPS Estimate: $-5.48
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-5.48 | — | — |
| Dec 2025 | $-5.19 | $-10.15 | $-4.96 |
| Sep 2025 | $-7.24 | $-5.76 | +$1.48 |
| Jun 2025 | $-9.79 | $-6.42 | +$3.37 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$5.6M | -$3.2M | -$4.3M | -$2.4M | -$3.2M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -183.9% | -191.5% | -183.9% | -183.9% | -183.9% | -130.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.93 | 1.92 | 0.93 | 0.93 | 0.93 | 0.31 |
| Current Ratio | 10.22 | 4.94 | 10.22 | 10.22 | 10.22 | 5.81 |
Key Ratios
ROA (TTM)
-107.1%
P/B
1.1
EPS (TTM)
$-130.84
CF/Share
$-6.63
52W High
$114.00
52W Low
$4.93
$4.93
52-Week Range
$114.00
Financial Health
Free Cash Flow
-$2.2M
Net Debt
-$9.8M
Cash
$9.9M
Total Debt
$31K
As of Sep 30, 2025
How does CNSP compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
CNSP valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
1.1
▼
47%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
CNSP profitability vs Pharmaceuticals peers
ROE
-130.1%
▼
140%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-107.1%
▼
186%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
CNSP financial health vs Pharmaceuticals peers
D/E ratio
0.3
▼
80%
below
peers
(1.5)
vs Peers
vs Industry
Above avg
Current ratio
5.8
▲
73%
above
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
0.5
▼
46%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
CNSP fundamentals radar
CNSP
Peer median
Industry
CNSP profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CNSP vs peers: key metrics
Top Holders
Top 5: 20.03%Stonepine Capital Managemen…
7.87%
$119K
Ikarian Capital, LLC
7.39%
$112K
DRW Securities, LLC
2.49%
$38K
Boothbay Fund Management, L…
2.18%
$33K
UBS Group AG
0.10%
$1K
As of Dec 31, 2025
Latest News
No related news yet